Literature DB >> 24477578

Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery.

Adam Cuker1, Lubica Rauova, Douglas Bolgiano, William H Matthai, Mortimer Poncz, Barbara A Konkle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24477578      PMCID： PMC4043923          DOI： 10.1160/TH13-12-1012

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  11 in total

1.  Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia.

Authors:  J Amiral; F Bridey; M Dreyfus; A M Vissoc; E Fressinaud; M Wolf; D Meyer
Journal:  Thromb Haemost       Date:  1992-07-06       Impact factor: 5.249

2.  Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.

Authors:  Brendan M Everett; Robert Yeh; Shi Yin Foo; David Criss; Elizabeth M Van Cott; Michael Laposata; Edwin G Avery; William D Hoffman; Jennifer Walker; David Torchiana; Ik-Kyung Jang
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

3.  Platelet factor 4 binding to lipid A of Gram-negative bacteria exposes PF4/heparin-like epitopes.

Authors:  Krystin Krauel; Claudia Weber; Sven Brandt; Ulrich Zähringer; Uwe Mamat; Andreas Greinacher; Sven Hammerschmidt
Journal:  Blood       Date:  2012-08-31       Impact factor: 22.113

4.  Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery.

Authors:  T L Bauer; G Arepally; B A Konkle; B Mestichelli; S S Shapiro; D B Cines; M Poncz; S McNulty; J Amiral; W W Hauck; R N Edie; J D Mannion
Journal:  Circulation       Date:  1997-03-04       Impact factor: 29.690

5.  Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.

Authors:  Claire Pouplard; Marc Antoine May; Sandra Regina; Michel Marchand; Jacques Fusciardi; Yves Gruel
Journal:  Br J Haematol       Date:  2005-03       Impact factor: 6.998

6.  Studies of the immune response in heparin-induced thrombocytopenia.

Authors:  Theodore E Warkentin; Jo-Ann I Sheppard; Jane C Moore; Richard J Cook; John G Kelton
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

7.  Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters.

Authors:  Stephanie Pitsilos; Jennifer Hunt; Emile R Mohler; Anand M Prabhakar; Mortimer Poncz; Jennine Dawicki; Tigran Z Khalapyan; Megan L Wolfe; Ronald Fairman; Marc Mitchell; Jeffrey Carpenter; Michael A Golden; Douglas B Cines; Bruce S Sachais
Journal:  Thromb Haemost       Date:  2003-12       Impact factor: 5.249

8.  The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.

Authors:  Mary P Mullen; David L Wessel; Kristen C Thomas; Kimberlee Gauvreau; Ellis J Neufeld; Francis X McGowan; James A Dinardo
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

9.  Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.

Authors:  S Selleng; B Malowsky; U Strobel; A Wessel; T Ittermann; H-G Wollert; T E Warkentin; A Greinacher
Journal:  J Thromb Haemost       Date:  2009-09-28       Impact factor: 5.824

10.  Effect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.

Authors:  T J Gluckman; J B Segal; S P Schulman; E P Shapiro; T S Kickler; M M Prechel; J V Conte; J M Walenga; I Shafique; J J Rade
Journal:  J Thromb Haemost       Date:  2009-06-23       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.